The Effects of Oral vs. Intravaginal Hormonal Contraception [ethinylestradiol/desogestrel] on Vaginal Health.

Trial Profile

The Effects of Oral vs. Intravaginal Hormonal Contraception [ethinylestradiol/desogestrel] on Vaginal Health.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs Ethinylestradiol/desogestrel (Primary) ; Ethinylestradiol/etonogestrel (Primary)
  • Indications Pregnancy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Oct 2009 Results have been presented at the Annual Meeting of the American Society for Reproductive Medicine.
    • 05 Feb 2009 Planned number of patients changed from 30 to 14, as reported in clinicalTrials.gov record.
    • 05 Feb 2009 Status changed from recruiting to completed, as reported in clinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top